Just two years after the GDP of China surpassed that of Germany, China overtook Japan as the world’s second largest economy. While we understand that the GDP figure cannot represent everything, it was, nevertheless, still a monumental step in China’s economic development. Because of the country’s booming economy and business growth, many Chinese companies are looking overseas for opportunities to invest, as well as partners for business development and investment. This program provides the means for U.S. companies and Chinese companies to come together to forge new business opportunities.

• Three keynote speeches positioning the macro economic situation of US-China economical ties, Chinese reform of regulatory environment, and the strategies implemented by companies
• Three panels addressing specific issues against the backdrop of exploring new investment frontiers (see tentative program for more details)
• Four to five panelists addressing prominent issues.
• Ten minute presentation from each panelist, followed by a fifteen-minute moderated Q&A session. There will be a brief break between panels to allow the audience to absorb the discussion and to interact with the speakers on a personal level.
• Opportunity to network with our speakers and VIP guests at a banquet dinner
  

Within just 20 years after its official start, Chinese capital has become the second largest in the world, and it has made remarkable achievements in stimulating China's economy. Yet it is still increasingly important to accelerate the integration of China's capital market into the international system. Chinese leaders, recognizing such needs, attach great importance to the capital market and make efforts to obtain international discourse power, which provides an administrative buttress for the globalization of China's capital market. At the same time, difficulties and challenges for buy-out capital abound when foreign capitals enter China's market.Political hurdles, as usual, are the most contested issues. Recent massive attacks on US-listed Chinese companies by international short sellers have uncovered certain Chinese business practices that may be problematic.

Key Topics:

• How to speed up the reform of China’s capital market to effectively help Chinese enterprises share market resources and realize business expansion and globalization
• How to attract overseas investment with the aid of the capital market to improve China’s investment culture and promote the industrial upgrading and economic restructuring
• How to enhance the competition strength of the Chinese financial institutions when dealing with overseas business
• How to synchronize China’s regulatory and other capital market practices with foreign jurisdictions to minimize the cost of going out.

China's private equity industry has shown major growth in the past few years. Though both the number of PE investment cases and the total number of cases have reached historic highs, risks in China’s PE/VC industry still abound despite its rapid development. China’s PE/VC investments focus primarily on pre-IPOs and lack other diversified exit strategies. Moreover, China’s regulators, such as the National Development and Reform Commission and China Securities Regulatory Commission, compete to control this bourgeoning industry, exposing its enterprises to the risk of shifting administrative regimes.

Key Topics:

• What opportunities and challenges face the  PE/VC industry in the next decade with the rapid development of China's economy?
• Where are the bubble and risk in this industry?
• More and more overseas funds look to invest in China, as they compete with local funds, what are the advantages and disadvantages of each?
• What growth models can China's PE/VC industry borrow from overseas competitors and what are their unique characteristics?
• How can Chinese private investors benefit from growth abroad?

China's twelfth "Five-Year" plan will further promote investments in health care industry. In order to advance pharmaceutical product standards and improve industrial structure, the government will be committed to improving the concentration rate of the industry and present a positive stance on foreign investment in the next few years. In 2009, the number of foreign pharmaceutical companies (joint ventures or wholly-owned companies) accounted for about 30% of the total, with great expected growth potential. Multinational companies must work together with Chinese local enterprises as a way of entering local market. However, multinational companies still face challenges.

Key Topics:

• How can you win support from local governments in second tier cities?
• How can you cooperate with your local partners in every aspect in whole industrial chain?
• How can you connect with thousands of start-up pharmaceutical companies and provide financing to them?